Tapentadol IR

DRUG3 trials

Sponsors

Ortho-McNeil Janssen Scientific Affairs, LLC, Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Conditions

Back PainPostoperative PainSubstance Abuse Detection

Phase 3

Tapentadol IR vs Oxycodone IR vs Placebo in Acute Pain From Vertebral Compression Fracture Associated With Osteoporosis

CompletedNCT00771758

Ortho-McNeil Janssen Scientific Affairs, LLCBack Pain

Start: 2008-09-30End: 2009-12-31Updated: 2014-05-09

Safety and Efficacy of Tapentadol Immediate Release (IR) and Oxycodone IR for Treatment of Acute Post-op Pain Following Elective Arthroscopic (Surgery Using a Thin Flexible Scope) Shoulder Surgery

CompletedNCT00814580

Ortho-McNeil Janssen Scientific Affairs, LLCPostoperative Pain

Start: 2008-12-31End: 2010-03-31Updated: 2012-11-20

Unknown Phase

Risk of Shopping Behavior of Tapentadol Immediate-Release (IR) Compared to Oxycodone Immediate-Release (IR)

CompletedNCT01545778

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Substance Abuse Detection

Start: 2010-02-28End: 2012-02-29Updated: 2012-10-29